Client zone


NHS suspends all vaginal mesh procedures

The NHS has suspended all vaginal mesh procedures for treatment of stress induced urinary incontinence after reviewing a report into safety concerns. The report found that some women had suffered devastating complications from the quick fix procedure as a result of the mesh cutting into surrounding tissue and organs.

The review led by Baroness Julia Cumberlege came to the conclusion that they found no evidence on the benefits for treating urinary incontinence that would outweigh “the severity of human suffering caused by mesh complications”.

“We strongly believe that mesh must not be used to treat women with stress urinary incontinence until we can manage the risk of complications much more effectively,” she said. “We have not seen evidence on the benefits of mesh that outweighs the severity of human suffering caused by mesh complications. I have been appalled at the seriousness and scale of the tragic stories we have heard from women and their families. We have heard from many women who are suffering terribly.”

 

How will Brexit affect the UK’s medical technology industry?

An interesting interview with Jonathan Evans of the ABHI on the future of the UK med tech sector and how Brexit might affect a number of key issues in the UK market.

The main concern from my point of view is that it all seems up in the air and until we start getting some firm assurances from both parties, I think the uncertainty will be more of an issue than anything else. People can not rely on the hope that “everything will be OK in the end” when we have an already at capacity health service, a shortage of staff and a lack of funding. Inevitably, the people that matter, the nurses, doctors and administrators, will end up turning away from the NHS to find a more secure future for themselves if the uncertainty remains.

 

https://www.medicaldevice-network.com/features/will-brexit-affect-uks-medical-technology-industry/

Johnson & Johnson agree deal to sell Lifescan for $2.1 B

Johnson & Johnson agree to a $2.1 billion offer from private equity shop Platinum Equity for its LifeScan blood glucose monitoring unit. This follows their wrapping up of the insulin pump brand Animas in Q4 of 2017.

Platinum Equity are not new to healthcare having set up SourceOne Healthcare technologies, an imaging products seller, on the back of buying healthcare divisions from Philips and PSS World Medical in 2002.

More at:

https://www.massdevice.com/johnson-johnson-moves-closer-to-exiting-the-diabetes-business-with-2-1b-lifescan-sale/

‘The NHS is creating drug addicts.’

With nearly 24 million opioids prescribed in 2017, experts warn that the NHS is creating an addiction crisis in the UK.

The powerful painkillers were being ‘dished out’ at a rate of 2,700 packs an hour leading to an increase in painkiller related deaths across the UK. In 2016 alone some 3,700 people died and this is only going up.

 

You can read more at:

http://www.bbc.co.uk/news/uk-england-43304375

Referral Scheme

Candidate Tools

Join our Mailing list

G2 Academy

Contact Us

We offer a national recruitment service from our Surrey head office, please see contact details below.

Head Office

Send Business Centre
3 Tannery House
Tannery Lane
Send, Surrey
GU23 7EF

T: 01483 910 940
E: sales@g2hr.com

  • 10
  • Jul 2018

NHS suspends all vaginal mesh procedures

Read More

Work
for Us

Find out More